Abstract
[See related article at [www.cmaj.ca/lookup/doi/10.1503/cmaj.190098][2]][2] KEY POINTS Between 2010 and 2015, many patents for blockbuster drugs expired, and pharmaceutical companies were faced with competition from the makers of generic versions (“generics”). It was called the “patent cliff
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.